What is Ideaya Biosciences (idya) stock price today?
IDEAYA Biosciences, Inc.'s stock symbol is IDYA and currently trades under NASDAQ. It’s current price per share is approximately $ 22.89. What are your IDEAYA Biosciences, Inc. (IDYA) stock predictions?
What is the upside for Ideaya Biosciences'stock?
Their forecasts range from $27.00 to $38.00. On average, they anticipate IDEAYA Biosciences' stock price to reach $32.29 in the next year. This suggests a possible upside of 45.0% from the stock's current price. View analysts' price targets for IDEAYA Biosciences or view top-rated stocks among Wall Street analysts.
When did Ideaya Biosciences'stock go public?
When did IDEAYA Biosciences IPO? (IDYA) raised $70 million in an initial public offering on Thursday, May 23rd 2019. The company issued 5,000,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan, Citigroup and Jefferies acted as the underwriters for the IPO. What is IDEAYA Biosciences' stock symbol?
What did idya Biosciences announce?
IDEAYA Biosciences, Inc. (Nasdaq:IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a clinical data update for the Phase 1/2 trial evaluating darovasertib and crizotinib synthetic lethal combination in metastatic uveal melanoma (MUM) patients.
Is Ideaya a buy?
IDEAYA Biosciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Should I buy IDYA stock?
The consensus among 2 Wall Street analysts covering (NASDAQ: IDYA) stock is to Strong Buy IDYA stock.
Should I buy or sell IDEAYA Biosciences stock right now?
4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for IDEAYA Biosciences in the last year. There are currently 4 buy ra...
What is IDEAYA Biosciences' stock price forecast for 2022?
4 equities research analysts have issued 1-year price targets for IDEAYA Biosciences' stock. Their forecasts range from $20.00 to $46.00. On averag...
How has IDEAYA Biosciences' stock performed in 2022?
IDEAYA Biosciences' stock was trading at $23.64 at the beginning of 2022. Since then, IDYA shares have decreased by 51.8% and is now trading at $11...
When is IDEAYA Biosciences' next earnings date?
IDEAYA Biosciences is scheduled to release its next quarterly earnings announcement on Tuesday, August 9th 2022. View our earnings forecast for ID...
How were IDEAYA Biosciences' earnings last quarter?
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) posted its earnings results on Tuesday, May, 10th. The company reported ($0.36) earnings per share for the q...
Who are IDEAYA Biosciences' key executives?
IDEAYA Biosciences' management team includes the following people: Mr. Yujiro S. Hata , Co-Founder, CEO, Pres & Director (Age 48, Pay $798.72k)...
Who are some of IDEAYA Biosciences' key competitors?
Some companies that are related to IDEAYA Biosciences include OPKO Health (OPK) , HUTCHMED (HCM) , Aurinia Pharmaceuticals (AUPH) , Arcus Biosc...
What other stocks do shareholders of IDEAYA Biosciences own?
Based on aggregate information from My MarketBeat watchlists, some companies that other IDEAYA Biosciences investors own include Aldeyra Therapeut...
When did IDEAYA Biosciences IPO?
(IDYA) raised $70 million in an initial public offering (IPO) on Thursday, May 23rd 2019. The company issued 5,000,000 shares at $13.00-$15.00 per...
About IDEAYA Biosciences
IDEAYA Biosciences (NASDAQ:IDYA) Frequently Asked Questions
IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations.
